The menopause is defined rigorously as the cessation of menstruation a
s a result of ovarian follicular depletion. Although in common clinica
l usage, the term is used to encompass the menopausal transition, a pe
riod which may average 4 years in duration, and during which alteratio
ns in menstrual regularity and/or flow may be accompanied by somatic o
r psychological symptoms. Measurement of serum follicle-stimulating ho
rmone (FSH) with or without oestradiol (E2) is frequently advocated as
providing a useful indicator of menopausal status. Several studies ha
ve shown an increase in serum FSH, with or without decrease in E2, in
women over the age of 40 years who continue to cycle regularly. Abrupt
fluctuations in serum FSH and E2 may be observed, with typically post
menopausal levels subsequently returning to the normal reproductive r
ange. In a cross sectional study, of regularly cycling women randomly
selected from the Melbourne community, and over the age of 45 years, 7
% had FSH levels typical of the post menopause, and 39% had levels abo
ve those found during the follicular phase in women aged less than 35
years. It is concluded that serum FSH is of little diagnostic value in
the assessment of menopausal status, which can currently be made only
on clinical grounds. An elevated serum FSH level cannot tell us relia
bly 'when it is all over'.